Literature DB >> 3094680

Splenic irradiation in treating warm autoimmune haemolytic anaemia.

H Markus, J C Forfar.   

Abstract

An elderly man with severe congestive heart failure was noted to have a haemoglobin concentration of 87 g/l and a reticulocyte count of 13%. Direct Coombs test yielded a positive result and the serum contained a moderate amount of warm antibody (IgG class). Steroids were given, but to no avail, and the patient's condition precluded splenectomy. A course of splenic irradiation was therefore tried (midline dose 2000 cGy (rads)), and 60 days later the blood film showed similar appearances to those in patients treated successfully by splenectomy. Haemoglobin concentration subsequently rose to normal. Splenic irradiation may offer a simple treatment for resistant warm autoimmune haemolytic anaemia when splenectomy is contraindicated.

Entities:  

Mesh:

Year:  1986        PMID: 3094680      PMCID: PMC1341632          DOI: 10.1136/bmj.293.6551.839

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  [Hemolytic hypersplenism: presence of antibodies with atypical characteristics].

Authors:  G SOKAL
Journal:  Rev Belg Pathol Med Exp       Date:  1957-04

2.  [The description of two severe cases of acquired idiopathic hemolytic anemia].

Authors:  F HENI; K BLESSING
Journal:  Klin Wochenschr       Date:  1954-06-01

3.  Splenectomy in blood dyscrasias.

Authors:  C S WELCH; W DAMESHEK
Journal:  N Engl J Med       Date:  1950-04-20       Impact factor: 91.245

  3 in total
  2 in total

1.  Hereditary spherocytosis with congestive heart failure: report of a case.

Authors:  M Morita; M Hashizume; T Kanematsu; K Sugimachi; K Makizumi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 2.  Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation.

Authors:  Christopher C Dvorak; Mignon L Loh
Journal:  Front Pediatr       Date:  2014-03-28       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.